Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
91.83
-6.99 (-7.07%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $5.96 billion as of September 18, 2026. Its market cap has increased by 62.28% in one year.
Market Cap
5.96B
Enterprise Value
6.29B
1-Year Change
62.28%
Ranking
Category
Stock Price
$91.83
ChartMarket Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $5.96B, an increase of 1,906.12%. That is a compound annual growth rate of 51.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 5.96B | 46.06% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.86B |
| Rhythm Pharmaceuticals | 6.82B |
| CG Oncology | 6.70B |
| Oruka Therapeutics | 6.47B |
| Travere Therapeutics | 6.10B |
| Scholar Rock Holding | 5.97B |
| Cogent Biosciences | 5.76B |
| Ligand Pharmaceuticals | 5.68B |